GGrantIndex
Sort

40,608 grants matching prostate cancer

Nipple Fluid Hormone Levels and Breast Cancer Risk

$510,273
Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2010 · CA

Behavioral Science Education - Cancer Prevention and Control

$510,253
Patricia Dolan Mullen · University Of Texas Hlth Sci Ctr Houston · R25 · FY2012 · CA

Prostate Microenvironmental & Prostate Cancer Progression

$510,214
June Ml Chan · University Of California, San Francisco · R01 · FY2006 · CA

Evaluation of novel therapies for vesicant skin toxicities

$510,078
Rajesh Agarwal · National Jewish Health · U54 · FY2011 · ES

Molecular Pathology of Cancer

$510,015
Michael Emmert-Buck · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Statistical Methods for Genetic Epidemiology

$509,996
Stanford University · R01 · FY2002 · CA

Heparan Sulfate in Prostate Cancer

$509,930
Lianchun Wang · University Of South Florida · U01 · FY2022 · CA

Mechanisms of resistance to treatment in aggressive prostate cancers

$509,873
Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Molecular alterations driving the development of primary prostate cancers

$509,873
Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

TARGETING DANGER-SENSING PATTERN RECOGNITION RECEPTORS FOR PROSTATE CANCER THERAPY

$509,835
Virginia Commonwealth University · · FY2011 · Department of Defense

PROSPECTIVE STUDY OF DIET AND CANCER IN MEN (HEALTH PROFESSIONALS FOLLOWUP)

$509,810
Harvard University (Medical School) · P01 · FY2000 · CA

Outcomes of Triaged Family Care in Advanced Cancer

$509,674
Laurel L. Northouse · University Of Michigan At Ann Arbor · R01 · FY2007 · CA

Genotypic and Phenotypic Studies of Inflammation in PCPT

$509,598
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA

DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications

$509,544
Alan Ashworth · University Of California, San Francisco · R01 · FY2022 · CA

MCG Minority-Based Community Clinical Oncology Program

$509,490
Anand P Jillella · Augusta University · U10 · FY2010 · CA

Novel, Noninvasive, Rapid Tumor Ablation Technology using Histotripsy

$509,478
Zhen Xu · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

A SINGLE MISSENSE MUTATION IN 77% OF PROSTATE CANCER BONE METASTASES: NOVEL OPPORTUNITY FOR GENETIC BIOMARKER AND NOVEL THERAPEUTIC MITOCHONDRIAL TAR

$509,451
Emory University · · FY2016 · Department of Defense

Prostate Cancer Harbinger Genes

$509,402
Mark A. Rubin · Brigham And Women'S Hospital · R01 · FY2006 · AG

Varicella virus antigens in glioma etiology and survival

$509,396
Joseph Leo Wiemels · University Of California, San Francisco · U01 · FY2016 · CA

Academic-Industrial Partnership for Translation of Acoustic Angiography

$509,325
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA

Intra-procedure Deformable Ultrasound-MRI Fusion for Prostate Biopsies

$509,295
Xenophon Papademetris · Zmk Medical Technologies, D/B/A Eigen · R42 · FY2016 · CA

HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities

$509,271
Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Targeting Early Drivers of Prostate Cancer Lineage Plasticity

$509,246
Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Descriptive Studies and Record Linkage

$509,014
Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA

MicroRNAs in the Progression and Metastisis of Prostate Cancer

$509,008
Rajvir Dahiya · University Of California, San Francisco · R01 · FY2014 · CA